Immunovaccine (Canada)

645 papers and 54.4k indexed citations i.

About

In recent decades, authors affiliated with Immunovaccine (Canada) have published 645 papers, which have received a total of 54.4k indexed citations. Scholars at this organization have produced 337 papers in Molecular Biology, 230 papers in Oncology and 106 papers in Cancer Research on the topics of Immunotherapy and Immune Responses (53 papers), Estrogen and related hormone effects (39 papers) and Cancer-related Molecular Pathways (33 papers). Their work is cited by papers focused on Molecular Biology (27.8k citations), Oncology (19.2k citations) and Cancer Research (10.5k citations). Authors at Immunovaccine (Canada) collaborate with scholars in Canada, United States and Russia and have published in prestigious journals including Journal of Clinical Oncology, Journal of Neuroscience and The Journal of Immunology. Some of Immunovaccine (Canada)'s most productive authors include Steven Grant, Carlos L. Arteaga, Paul Dent, Marc Mansour and Genevieve Weir.

In The Last Decade

Fields of papers published by authors at Immunovaccine (Canada)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Immunovaccine (Canada) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Immunovaccine (Canada)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Immunovaccine (Canada). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Immunovaccine (Canada) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immunovaccine (Canada) more than expected).

Rankless by CCL
2025